Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.94 CAD | +10.36% | +17.61% | +35.86% |
05-17 | XORTX Therapeutics Reprices Warrants Connected With U.S. IPO | MT |
05-17 | XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.86% | 7.57M | |
+10.53% | 115B | |
+12.26% | 106B | |
-4.33% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.32% | 17.56B | |
-40.50% | 17.32B | |
+6.08% | 14.03B | |
+30.96% | 12.13B |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Therapeutics Names James Fairbairn Interim Chief Financial Officer; Shares Gain